Amyloid-β and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer's disease

This study was designed to test the interaction between amyloid-β and tau proteins as a determinant of metabolic decline in preclinical Alzheimer's disease (AD). We assessed 120 cognitively normal individuals with [(18)F]florbetapir positron emission tomography (PET) and cerebrospinal fluid (CS...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Mol Psychiatry
Glavni autori: Pascoal, T A, Mathotaarachchi, S, Mohades, S, Benedet, A L, Chung, C-O, Shin, M, Wang, S, Beaudry, T, Kang, M S, Soucy, J-P, Labbe, A, Gauthier, S, Rosa-Neto, P
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2017
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5262471/
https://ncbi.nlm.nih.gov/pubmed/27021814
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mp.2016.37
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items